64) Human mesenchymal stem cells (hMSCs) adher |
65) Human mesenchymal stem cells (hMSCs) or au |
66) sed on understanding the reasons why some human mesenchymal stem cell (hMSC) samples |
67) For SaBP, human mesenchymal stem cells (HMSCs), umbi |
68) y the trapping and potential targeting of human mesenchymal stem cells (MSCs) during |
69) ic properties by culturing with mouse and human mesenchymal stem cells (MSCs). |
70) the ability of osteogenic differentiated human mesenchymal stem cells (O-hMSCs) to |
71) of tissue engineering is the use of adult human mesenchymal stem cells (hMSCs) as an |
72) Although Human papillomavirus (HPV) is a common sex |
73) Human papillomavirus has largely been fram |
74) ines recommending vaccination against the human papillomavirus (HPV) and widespread |
75) velopment programme for a vaccine against human papillomavirus (HPV) will be present |
76) loped Markov model for the progression of human papillomavirus (HPV-16) infection wa |
77) study, we found that women infected with human papillomavirus (n = 154) experienced |
78) to explore a theoretical model explaining human papillomavirus vaccine intentions. |
79) that both men and women receive regarding human papillomavirus. |
80) Human bone marrow-derived mesenchymal stem |
81) rce of growth factors shown to facilitate human bone growth. |
82) of dedifferentiated fat cells (DFATs) and human bone marrow mesenchymal stem cells ( |
83) The hypothesis of this work was that human bone marrow-derived mesenchymal stem |
84) somes do not have any cytotoxic effect on human bone marrow-derived mesenchymal stem |
85) We tested both human bone marrow-derived mesenchymal stem |
86) m cell fraction (STRO-1 positive cell) of human bone marrow. |
87) ecting "opening a bottle" was explored in human subjects by electromyographic (EMG) |
88) nce and absence of a medical condition in human subjects is often modelled as an out |
89) Here, we assessed in healthy human subjects whether PFC subareas have d |
90) us controlled testing of interventions on human subjects. |
91) re analyzed in postmortem tissues from 20 human subjects. |
92) s of topical sildenafil on PrU healing in human subjects. |
93) gh recidivism and poor study retention in human subjects. |
94) Human umbilical cord blood (hUCB) has been |
95) Human umbilical vessels have been recogniz |
96) MSCs were isolated from human umbilical cord or adipose tissue. |
add keyword